Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis

被引:16
作者
Amezcua-Guerra, L. M.
Hernandez-Martinez, B.
Pineda, C.
Bojalil, R.
机构
[1] Inst Nacl Cardiol Ignacio Chavez, Dept Immunol, Mexico City 14080, DF, Mexico
[2] Inst Nacl Cardiol Ignacio Chavez, Dept Rheumatol, Mexico City 14080, DF, Mexico
关键词
D O I
10.1136/gut.2006.095539
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1059 / 1060
页数:3
相关论文
共 11 条
[1]   Rheumatoid arthritis associated with ulcerative colitis [J].
Adachi, Y ;
Hinoda, Y ;
Takahashi, H ;
Nakagawa, N ;
Sakamoto, H ;
Itoh, F ;
Endo, T ;
Suzuki, S ;
Imai, K .
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) :590-595
[2]   Liaison between rheumatoid arthritis and ulcerative colitis [J].
Aydin, Y ;
Özçakar, L ;
Yidiz, M ;
Akinci, A .
RHEUMATOLOGY INTERNATIONAL, 2003, 23 (01) :47-48
[3]  
Boyer F, 2001, ANN RHEUM DIS, V60, P901
[4]   The B7 family revisited [J].
Greenwald, RJ ;
Freeman, GJ ;
Sharpe, AH .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :515-548
[5]   Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution [J].
Heller, F ;
Florian, P ;
Bojarski, C ;
Richter, J ;
Christ, M ;
Hillenbrand, B ;
Mankertz, J ;
Gitter, AH ;
Bürgel, N ;
Fromm, M ;
Zeitz, M ;
Fuss, I ;
Strober, W ;
Schulzke, JD .
GASTROENTEROLOGY, 2005, 129 (02) :550-564
[6]   Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig [J].
Kremer, JM ;
Westhovens, R ;
Leon, M ;
Di Giorgio, E ;
Alten, R ;
Steinfeld, S ;
Russell, A ;
Dougados, M ;
Emery, P ;
Nuamah, IF ;
Williams, GR ;
Becker, JC ;
Hagerty, DT ;
Moreland, LW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1907-1915
[7]   Structural analysis of CTLA-4 function in vivo [J].
Masteller, EL ;
Chuang, E ;
Mullen, AC ;
Reiner, SL ;
Thompson, CB .
JOURNAL OF IMMUNOLOGY, 2000, 164 (10) :5319-5327
[8]  
Miller FW, 2000, ARTHRITIS RHEUM, V43, P243, DOI 10.1002/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO
[9]  
2-K
[10]  
STEPHENS MDB, 1987, ADVERSE DRUG REACT T, V6, P1